Skip to main content

Table 2 Sample frequencies of reported symptoms, vision results, and management

From: Academic performance and musculoskeletal pain in adolescents with uncorrected vision problems

  

Prescription group (n = 61)

Control group (n = 91)

n (%)

n (%)

Symptoms; eye examinationa

Blurred vision at distance

54 (89)**

7 (8)

Headache

22 (36)

21 (23)

No vision related symptoms

0 (0)**

66 (73)

Symptoms in general; questionnaireb

Eye pain

44 (72)

48 (53)

 

2.6 ± 2.1

1.7 ± 1.9

Headache

53 (87)

75 (82)

 

3.8 ± 2.4

2.9 ± 2.1

Neck pain

37 (61)

44 (48)

 

1.9 ± 2.0

1.4 ± 1.8

Shoulder pain

40 (66)**

39 (43)

 

2.1 ± 2.0**

1.1 ± 1.5

Lower back pain

34 (56)

39 (43)

 

1.5 ± 1.8

1.4 ± 2.0

Symptoms during screen use; questionnaireb

Eye pain

47 (77)

63 (69)

 

2.8 ± 2.1

2.3 ± 2.0

Headache

51 (84)

74 (81)

 

3.2 ± 2.3

3.1 ± 2.3

Neck pain

43 (71)

49 (54)

 

2.0 ± 1.6

1.5 ± 1.8

Shoulder pain

40 (66)**

36 (40)

 

1.9 ± 1.7**

1.0 ± 1.6

Lower back pain

35 (57)

39 (43)

 

1.6 ± 1.8

1.3 ± 1.8

Continuous reading/screen viewing ability

 

26 (43)*

54 (59)

Screen time (hours/day, mean ± SD)

Weekday (Sunday – Friday)

2.2 ± 1.4

2.0 ± 1.2

Weekend (Saturday)

3.8 ± 2.2

4.1 ± 2.1

Ametropia (Cycloplegic SER, D)

Emmetropia (> -0.50 D, < +0.50 D)

0 (0)

74 (81)

Low myopia (> -3.00 D, ≤ -0.50 D)

55 (90)

10 (11)

High myopia (≤ -5.00 D)

0 (0)

1 (1)

Low hyperopia ( ≥ + 0.50 D, ≤ +2.00 D)

6 (10)

6 (7)

Anisometropia (≥ 1.00 D)

0 (0)

0 (0)

Hab VA RE (6 m)

LogMAR (≤ 0.0) [decimal ≥ 1.0]

6 (10)**

73 (80)

LogMAR (≤ 0.1, > 0.0) [decimal < 1.0, ≥ 0.8]

1 (2)

5 (6)

LogMAR (≤ 0.3, > 0.1) [decimal < 0.8, ≥ 0.5]

11 (18)**

0 (0)

LogMAR (> 0.3) [decimal < 0.5]

40 (66)**

0 (0)

Best corrected VA RE (6 m)

LogMAR (≤ 0.0) [decimal ≥ 1.0]

51 (84)

85 (93)

LogMAR (≤ 0.1, > 0.0) [decimal < 1.0, ≥ 0.8]

10 (16)

6 (7)

LogMAR (≤ 0.3, > 0.1) [decimal < 0.8, ≥ 0.5]

0 (0)

0 (0)

LogMAR (> 0.3) [decimal < 0.5]

0 (0)

0 (0)

Heterophoria (6 m)

Orthophoria

59 (97)

90 (99)

Esophoria > 1 ΔBO

1 (2)

1 (1)

Exophoria > 2 ΔBI

1 (2)

0 (0)

Heterophoria (40 cm)

Orthophoria

57 (93)

87 (96)

Esophoria > 0 ΔBO

1 (2)

2 (2)

Exophoria > 6 ΔBI

3 (5)

2 (2)

NPC (cm)

≤ 10

58 (95)

91 (100)

> 10 < 25

3 (5)

0 (0)

AA BIN (D)

> 8

53 (87)**

90 (99)

≤ 8

8 (13)**

1 (1)

Management - prescription of new glasses

Low myopia and blurred vision at distance

54 (89)

 

Low hyperopia and headache

6 (10)

 

Change of ≥ 0.50 best corrected SER (myopia)

1 (2)

 
  1. SER: spherical equivalent error in diopter (D), RE: right eye, VA: visual acuity, Hab: habitual, NPC: near point of convergence (cm), Heterophoria: prism diopter base in (ΔBI) or base out (ΔBO), AA: amplitude of accommodation (D), BIN: binocular (both eyes). aNone of the participants reported double vision, eye pain, or blurred vision at near. bSymptoms in general and during screen use are reported as frequencies and average pain scores (mean ± SD) (Wong-Baker FACES Pain Rating Scale). Habitual VA data were missing for three children in the prescription group and 13 children in the control group. *Statistically significant difference between groups (p < 0.05). **Statistically significant difference between groups with Bonferroni adjusted alpha levels